Skip to main content

MARSHALL WACE, LLP

Position in DHR — Danaher Corp /De/

CIK 1318757 LONDON, X0

Position in DHR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$493,152
-$1,497,648 QoQ
Shares Held
2,589
-75.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,367
of 2,098 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in DHR Over Time

Shares Held

Position Value (USD)

Derivatives in DHR

reported options exposure · as of Mar 31, 2026
CallValue
$18,960
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $872,920,182 across 27 Diagnostics & Research names. DHR ranks #22 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DHR

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $493,152 2,589
2026-03-31 $1,990,800 10,500
2026-03-31 $18,960 100
2025-09-30 $79,304,000 400,000
2025-06-30 $166,908,261 844,934
2025-03-31 $739,229,180 3,605,996
2024-12-31 $102,301,022 445,659
2024-09-30 $304,546,165 1,095,411
2024-06-30 $476,836,724 1,908,492
2024-03-31 $729,472,573 2,921,162
2023-12-31 $411,317,892 1,777,980
2023-09-30 $584,663,009 2,356,562
2023-06-30 $263,541,652 1,098,090
2023-03-31 $343,941,823 1,364,632
2023-03-31 $11,669,451 46,300
2022-12-31 $211,459,831 796,699
2022-12-31 $3,689,337 13,900
2022-12-31 $2,972,703 11,200
2022-09-30 $22,242,643 86,115
2022-03-31 $20,424,272 69,629
2021-12-31 $109,511,624 332,852
2021-09-30 $41,851,668 137,471
2021-06-30 $131,724,236 490,849
2021-03-31 $30,756,955 136,649
2020-12-31 $86,247,621 388,258
2020-09-30 $22,854,696 106,138
2020-06-30 $56,164,750 317,620